Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    The webpage now includes an invitation to a conference call and a declaration of a dividend by Pfizer, while it has removed updates on research and vaccine recommendations.
    Difference
    19%
    Check dated 2025-06-27T00:24:53.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include new research findings and corporate announcements from Pfizer, particularly regarding advancements in cancer treatment and vaccine recommendations. Notably, the deletion of previous announcements indicates a shift in focus towards more recent developments.
    Difference
    3%
    Check dated 2025-06-05T11:06:11.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The webpage has removed several significant press releases related to Pfizer's financial results, licensing agreements, and vaccine approvals, while adding new press releases that highlight ongoing research and corporate updates.
    Difference
    86%
    Check dated 2025-05-29T05:49:04.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The webpage has updated its content to reflect a new corporate licensing agreement involving Pfizer and 3SBio, while removing a previous announcement about a healthcare conference webcast.
    Difference
    10%
    Check dated 2025-05-22T02:13:32.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The webpage has added several important updates regarding Pfizer's financial performance and advancements in cancer treatment, while removing previous announcements about specific drug approvals and clinical trial results.
    Difference
    44%
    Check dated 2025-04-30T13:46:17.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The page now includes an important update regarding the expansion of the recommendation for Pfizer’s RSV vaccine to include adults aged 50 to 59 at increased risk of disease. However, a previous mention of Pfizer's advancements in genitourinary cancers has been removed.
    Difference
    12%
    Check dated 2025-04-23T08:17:03.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.